For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Geovax Labs Inc (NASDAQ: GOVX) closed at $0.56 in the last session, up 1.83% from day before closing price of $0.55. In other words, the price has increased by $1.83 from its previous closing price. On the day, 0.87 million shares were traded. GOVX stock price reached its highest trading level at $0.58 during the session, while it also had its lowest trading level at $0.5481.
Ratios:
We take a closer look at GOVX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.03 and its Current Ratio is at 2.03. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on April 15, 2025, Reiterated its Buy rating but revised its target price to $14 from $18 previously.
On April 15, 2025, Alliance Global Partners reiterated its Buy rating and also upped its target price recommendation from $15 to $8.50.
On November 11, 2024, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $15.Alliance Global Partners initiated its Buy rating on November 11, 2024, with a $15 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 07 ’25 when McKee Kelly T. Jr. bought 1,107 shares for $0.67 per share. The transaction valued at 742 led to the insider holds 3,494 shares of the business.
SPENCER JOHN N JR bought 10,000 shares of GOVX for $9,800 on Apr 10 ’25. The Director now owns 11,402 shares after completing the transaction at $0.98 per share. On Apr 10 ’25, another insider, Sharkey John W., who serves as the VP, Business Development of the company, bought 6,000 shares for $0.99 each. As a result, the insider paid 5,940 and bolstered with 6,191 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GOVX now has a Market Capitalization of 16715205 and an Enterprise Value of 11175981. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.72 while its Price-to-Book (P/B) ratio in mrq is 3.18. Its current Enterprise Value per Revenue stands at 1.819 whereas that against EBITDA is -0.448.
Stock Price History:
The Beta on a monthly basis for GOVX is 3.35, which has changed by -0.70677084 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, GOVX has reached a high of $3.88, while it has fallen to a 52-week low of $0.43. The 50-Day Moving Average of the stock is -11.94%, while the 200-Day Moving Average is calculated to be -45.41%.
Shares Statistics:
According to the various share statistics, GOVX traded on average about 884.78K shares per day over the past 3-months and 687790 shares per day over the past 10 days. A total of 29.71M shares are outstanding, with a floating share count of 29.62M. Insiders hold about 0.30% of the company’s shares, while institutions hold 6.82% stake in the company. Shares short for GOVX as of 1760486400 were 3107100 with a Short Ratio of 3.51, compared to 1757894400 on 3794469. Therefore, it implies a Short% of Shares Outstanding of 3107100 and a Short% of Float of 10.4899995.
Earnings Estimates
At present, 4.0 analysts are actively evaluating the performance of Geovax Labs Inc (GOVX) in the stock market.The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.16 and low estimates of -$0.33.
Analysts are recommending an EPS of between -$0.49 and -$1.4 for the fiscal current year, implying an average EPS of -$1.08. EPS for the following year is -$1.33, with 3.0 analysts recommending between -$0.61 and -$2.54.
